Vanguard Group’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$641K Sell
2,349,317
-6,378
-0.3% -$2.43K ﹤0.01% 3889
2025
Q3
$1.07M Buy
2,355,695
+172,824
+8% +$101K ﹤0.01% 3770
2025
Q2
$1.39M Hold
2,182,871
﹤0.01% 3655
2025
Q1
$2.04M Buy
2,182,871
+3,187
+0.1% +$3.5K ﹤0.01% 3487
2024
Q4
$2.09M Hold
2,179,684
﹤0.01% 3550
2024
Q3
$1.99M Buy
2,179,684
+34,556
+2% +$32.4K ﹤0.01% 3558
2024
Q2
$1.47M Hold
2,145,128
﹤0.01% 3665
2024
Q1
$1.34M Buy
2,145,128
+373
+0% +$245 ﹤0.01% 3719
2023
Q4
$1.48M Buy
2,144,755
+380
+0% +$303 ﹤0.01% 3706
2023
Q3
$1.97M Hold
2,144,375
﹤0.01% 3585
2023
Q2
$1.87M Hold
2,144,375
﹤0.01% 3685
2023
Q1
$1.93M Hold
2,144,375
﹤0.01% 3684
2022
Q4
$1.03M Buy
2,144,375
+983
+0% +$636 ﹤0.01% 3907
2022
Q3
$1.69M Hold
2,143,392
﹤0.01% 3809
2022
Q2
$1.96M Hold
2,143,392
﹤0.01% 3815
2022
Q1
$3.26M Sell
2,143,392
-8,982
-0.4% -$13.1K ﹤0.01% 3734
2021
Q4
$4.43M Sell
2,152,374
-2,890
-0.1% -$6.36K ﹤0.01% 3680
2021
Q3
$4.03M Buy
2,155,264
+35,561
+2% +$65.8K ﹤0.01% 3787
2021
Q2
$5.19M Sell
2,119,703
-406,858
-16% -$987K ﹤0.01% 3584
2021
Q1
$9.02M Sell
2,526,561
-19,259
-0.8% -$66K ﹤0.01% 3205
2020
Q4
$5.4M Sell
2,545,820
-65,219
-2% -$115K ﹤0.01% 3328
2020
Q3
$3.63M Buy
2,611,039
+751,729
+40% +$1.31M ﹤0.01% 3298
2020
Q2
$3.63M Buy
1,859,310
+990,303
+114% +$1.81M ﹤0.01% 3238
2020
Q1
$1.09M Buy
869,007
+333,841
+62% +$602K ﹤0.01% 3466
2019
Q4
$744K Buy
535,166
+284,931
+114% +$338K ﹤0.01% 3702
2019
Q3
$208K Buy
250,235
+115,748
+86% +$70.2K ﹤0.01% 3955
2019
Q2
$48K Buy
134,487
+35,886
+36% +$13.1K ﹤0.01% 4110
2019
Q1
$33K Buy
98,601
+20,000
+25% +$7.35K ﹤0.01% 4087
2018
Q4
$26K Buy
78,601
+470
+0.6% +$252 ﹤0.01% 4109
2018
Q3
$58K Buy
78,131
+5,834
+8% +$4.65K ﹤0.01% 4114
2018
Q2
$57K Buy
72,297
+2,060
+3% +$1.61K ﹤0.01% 4093
2018
Q1
$51K Buy
70,237
+3,500
+5% +$3.38K ﹤0.01% 4065
2017
Q4
$79K Buy
66,737
+14,200
+27% +$16.7K ﹤0.01% 4011
2017
Q3
$66K Buy
52,537
+11,737
+29% +$15.3K ﹤0.01% 4014
2017
Q2
$61K Buy
40,800
+1,400
+4% +$1.96K ﹤0.01% 4017
2017
Q1
$53K Buy
39,400
+16,488
+72% +$23.1K ﹤0.01% 4024
2016
Q4
$31K Buy
22,912
+4,200
+22% +$7.35K ﹤0.01% 4056
2016
Q3
$40K Buy
18,712
+5,167
+38% +$13K ﹤0.01% 4046
2016
Q2
$38K Hold
13,545
﹤0.01% 4094
2016
Q1
$20K Hold
13,545
﹤0.01% 4122
2015
Q4
$32K Buy
+13,545
New +$35K ﹤0.01% 4158

Other funds holding MLSS

Vanguard Group's MLSS Position: Q4 2025 in Review

Vanguard Group reduced its Milestone Scientific (MLSS) stake by 0.27% in Q4 2025, selling an estimated $2.43K and leaving 2,349,317 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #3889.

Vanguard Group first reported a position in MLSS in Q4 2015 and has held it in 41 quarters since. The position peaked at $9.02M in Q1 2021. 31 funds tracked by Wall St. Rank hold MLSS as of Q4 2025.

  • Vanguard Group held 2,349,317 shares of Milestone Scientific worth $641K as of Q4 2025.
  • Vanguard Group sold 6,378 Milestone Scientific shares in Q4 2025, an estimated $2.43K.
  • Milestone Scientific made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3889 holding.
  • Vanguard Group first reported a position in Milestone Scientific in Q4 2015 and has held it in 41 quarters since.
  • Vanguard Group's Milestone Scientific position peaked at $9.02M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.